The Trump Administration's in the Nation's Coronavirus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Preparedness: Responding to Biological Attacks, Pandemics, and Emerging Infec- Tious Disease Outbreaks
THE STATE OF U.S. PUBLIC HEALTH BIO- PREPAREDNESS: RESPONDING TO BIOLOGICAL ATTACKS, PANDEMICS, AND EMERGING INFEC- TIOUS DISEASE OUTBREAKS HEARING BEFORE THE SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS OF THE COMMITTEE ON ENERGY AND COMMERCE HOUSE OF REPRESENTATIVES ONE HUNDRED FIFTEENTH CONGRESS SECOND SESSION FRIDAY, JUNE 15, 2018 Serial No. 115–140 ( Printed for the use of the Committee on Energy and Commerce energycommerce.house.gov U.S. GOVERNMENT PUBLISHING OFFICE 35–127 WASHINGTON : 2019 VerDate Nov 24 2008 13:47 Feb 28, 2019 Jkt 037690 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 U:\MY DOCS\HEARINGS 115\HEARINGS\115-140 CHRIS COMMITTEE ON ENERGY AND COMMERCE GREG WALDEN, Oregon Chairman JOE BARTON, Texas FRANK PALLONE, JR., New Jersey Vice Chairman Ranking Member FRED UPTON, Michigan BOBBY L. RUSH, Illinois JOHN SHIMKUS, Illinois ANNA G. ESHOO, California MICHAEL C. BURGESS, Texas ELIOT L. ENGEL, New York MARSHA BLACKBURN, Tennessee GENE GREEN, Texas STEVE SCALISE, Louisiana DIANA DEGETTE, Colorado ROBERT E. LATTA, Ohio MICHAEL F. DOYLE, Pennsylvania CATHY MCMORRIS RODGERS, Washington JANICE D. SCHAKOWSKY, Illinois GREGG HARPER, Mississippi G.K. BUTTERFIELD, North Carolina LEONARD LANCE, New Jersey DORIS O. MATSUI, California BRETT GUTHRIE, Kentucky KATHY CASTOR, Florida PETE OLSON, Texas JOHN P. SARBANES, Maryland DAVID B. MCKINLEY, West Virginia JERRY MCNERNEY, California ADAM KINZINGER, Illinois PETER WELCH, Vermont H. MORGAN GRIFFITH, Virginia BEN RAY LUJA´ N, New Mexico GUS M. BILIRAKIS, Florida PAUL TONKO, New York BILL JOHNSON, Ohio YVETTE D. CLARKE, New York BILLY LONG, Missouri DAVID LOEBSACK, Iowa LARRY BUCSHON, Indiana KURT SCHRADER, Oregon BILL FLORES, Texas JOSEPH P. -
Biden-Harris Transition Announces COVID-19 Advisory Board
BIDEN-HARRIS TRANSITION The President-Elect The Vice President-Elect Priorities Transition Español NOVEMBER 09, 2020 PRESS RELEASES Biden-Harris Transition Announces COVID-19 Advisory Board Leading Public Health and Scientific Experts to Advise the Transition on COVID-19 Response WASHINGTON – Today, the Biden-Harris Transition announced the formation of the Transition COVID-19 Advisory Board, a team of leading public health experts who will advise President-elect Biden, Vice President-elect Harris, and the Transition’s COVID-19 staff. The Transition COVID-19 Advisory Board will be led by co-chairs Dr. David Kessler, Dr. Vivek Murthy, and Dr. Marcella Nunez-Smith. Dr. Beth Cameron and Dr. Rebecca Katz are serving as advisors to the Transition on COVID-19 and will work closely with the Advisory Board. “Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,” said President-elect Biden. “The advisory board will help shape my approach to managing the surge in reported infections; ensuring vaccines are safe, effective, and distributed efficiently, equitably, and free; and protecting at-risk populations.” New cases are rising in at least 40 states, with more than 9.3 million total infections and more than 236,000 deaths. President-elect Biden has pledged to bring leadership to the COVID pandemic, which continues to claim thousands of lives each week, by curbing the spread of the disease, providing free treatment to those in need, and elevating the voices of scientists and public health experts. The COVID-19 Advisory Board will help guide the Biden-Harris Transition in planning for the President-elect’s robust federal response. -
Libertarianism, Culture, and Personal Predispositions
Undergraduate Journal of Psychology 22 Libertarianism, Culture, and Personal Predispositions Ida Hepsø, Scarlet Hernandez, Shir Offsey, & Katherine White Kennesaw State University Abstract The United States has exhibited two potentially connected trends – increasing individualism and increasing interest in libertarian ideology. Previous research on libertarian ideology found higher levels of individualism among libertarians, and cross-cultural research has tied greater individualism to making dispositional attributions and lower altruistic tendencies. Given this, we expected to observe positive correlations between the following variables in the present research: individualism and endorsement of libertarianism, individualism and dispositional attributions, and endorsement of libertarianism and dispositional attributions. We also expected to observe negative correlations between libertarianism and altruism, dispositional attributions and altruism, and individualism and altruism. Survey results from 252 participants confirmed a positive correlation between individualism and libertarianism, a marginally significant positive correlation between libertarianism and dispositional attributions, and a negative correlation between individualism and altruism. These results confirm the connection between libertarianism and individualism observed in previous research and present several intriguing questions for future research on libertarian ideology. Key Words: Libertarianism, individualism, altruism, attributions individualistic, made apparent -
Periodicalspov.Pdf
“Consider the Source” A Resource Guide to Liberal, Conservative and Nonpartisan Periodicals 30 East Lake Street ∙ Chicago, IL 60601 HWC Library – Room 501 312.553.5760 ver heard the saying “consider the source” in response to something that was questioned? Well, the same advice applies to what you read – consider the source. When conducting research, bear in mind that periodicals (journals, magazines, newspapers) may have varying points-of-view, biases, and/or E political leanings. Here are some questions to ask when considering using a periodical source: Is there a bias in the publication or is it non-partisan? Who is the sponsor (publisher or benefactor) of the publication? What is the agenda of the sponsor – to simply share information or to influence social or political change? Some publications have specific political perspectives and outright state what they are, as in Dissent Magazine (self-described as “a magazine of the left”) or National Review’s boost of, “we give you the right view and back it up.” Still, there are other publications that do not clearly state their political leanings; but over time have been deemed as left- or right-leaning based on such factors as the points- of-view of their opinion columnists, the make-up of their editorial staff, and/or their endorsements of politicians. Many newspapers fall into this rather opaque category. A good rule of thumb to use in determining whether a publication is liberal or conservative has been provided by Media Research Center’s L. Brent Bozell III: “if the paper never met a conservative cause it didn’t like, it’s conservative, and if it never met a liberal cause it didn’t like, it’s liberal.” Outlined in the following pages is an annotated listing of publications that have been categorized as conservative, liberal, non-partisan and religious. -
Trump Sees Treason from Within Stephen Collinson CNN, September 6, 2018
Trump sees treason from within Stephen Collinson CNN, September 6, 2018 Washington (CNN) — It's impossible to know in the moment when a presidency begins to dissolve. But after a devastating 48 hours, it's already clear that Donald Trump's will never be the same. Whatever your view of Trump, his behavior and his presidency, Washington is watching the opening act of a stunning attempt to topple the elected leader of the nation. Damaging twin portraits of the President in a New York Times op-ed and Bob Woodward's new book are using the words of current top officials to fracture the mythology of vanity and bombast, conmanship and intimidation of Trump's personality cult. In an attack from an enemy within, top officials who see Trump up close, including one calling the band of renegades the "resistance," are finally daring to say -- albeit under Washington's invisibility cloak of anonymity -- what outside critics have long believed. They warn the President of the United States is not only unfit to be the most powerful man in the world, but is a venal mix of ignorance and ego, pettiness, malignancy and recklessness that is putting the republic and the world itself at risk. For all his boasts of historic success and self-image as a strongman's strongman, the "adults in the room" want Americans to know: the emperor has no clothes. "The root of the problem is the President's amorality. Anyone who works with him knows he is not moored to any discernible first principles that guide his decision making," the unnamed official wrote in the staggering essay published by the Times. -
Speaker Bios
SPEAKER BIOGRAPHIES The Honorable Deborah Birx, MD Deborah L. Birx, MD is Ambassador-at-Large and Coordinator of the United States government activities to combat HIV/AIDS globally. Ambassador Birx is a world-renowned medical expert and leader in the field of HIV/AIDS whose three decade-long career has focused on HIV/AIDS immunology, vaccine research, and global health. As the U.S. Global AIDS Coordinator, Ambassador Birx oversees the implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nation to combat a single disease in history, as well as all U.S. government engagement with the Global Fund to Fight AIDS, Tuberculosis, and Malaria. In 1985, Ambassador Birx began her career with the Department of Defense (DoD) as a military trained clinician in immunology, focusing on HIV/AIDS vaccine research. From 1985-1989 she served as an Assistant Chief of the Hospital Immunology Service at Walter Reed Army Medical Center. Through her professionalism and leadership in the field, she progressed to serve as the Director of the U.S. Military HIV Research Program (USMHRP) at the Walter Reed Army Institute of Research from 1996-2005. Ambassador Birx helped lead one of the most influential HIV vaccine trials in history (known as RV 144, or the Thai trial), which provided the first supporting evidence of any vaccine’s potential effectiveness in preventing HIV infection. During this time, she also rose to the rank of Colonel, bringing together the Navy, Army, and Air Force in a new model of cooperation – increasing the efficiency and effectiveness of the U.S. -
Minority Views
MINORITY VIEWS The Minority Members of the House Permanent Select Committee on Intelligence on March 26, 2018 submit the following Minority Views to the Majority-produced "Repo11 on Russian Active Measures, March 22, 2018." Devin Nunes, California, CMAtRMAN K. Mich.J OI Conaw ay, Toxas Pe1 or T. King. New York F,ank A. LoBiondo, N ew Jersey Thom.is J. Roonev. Florida UNCLASSIFIED Ileana ROS·l chtinon, Florida HVC- 304, THE CAPITOL Michnel R. Turner, Ohio Brad R. Wons1 rup. Ohio U.S. HOUSE OF REPRESENTATIVES WASHINGTON, DC 20515 Ou is S1cwart. U1ah (202) 225-4121 Rick Cr.,w ford, Arka nsas P ERMANENT SELECT C OMMITTEE Trey Gowdy, South Carolina 0A~lON NELSON Ellsr. M . S1nfn11ik, Nnw York ON INTELLIGENCE SrAFf. D IREC f()ti Wi ll Hurd, Tcxa~ T11\'10l !IV s. 8 £.R(.REE N At1am 8 . Schiff, Cohforn1a , M tNORllV STAFF OtR ECToq RANKIN G M EMtlER Jorncs A. Himes, Connec1icut Terri A. Sewell, AlabJma AndrC Carso n, lncli.1 na Jacki e Speier, Callfomia Mike Quigley, Il linois E,ic Swalwell, California Joilq u1 0 Castro, T exas De nny Huck, Wash ington P::iul D . Ry an, SPCAl([ R or TH( HOUSE Noncv r c1os1. DEMOC 11t.1 1c Lr:.11.orn March 26, 2018 MINORITY VIEWS On March I, 201 7, the House Permanent Select Commiltee on Intelligence (HPSCI) approved a bipartisan "'Scope of In vestigation" to guide the Committee's inquiry into Russia 's interference in the 201 6 U.S. e lection.1 In announc ing these paramete rs for the House of Representatives' onl y authorized investigation into Russia's meddling, the Committee' s leadership pl edged to unde1take a thorough, bipartisan, and independent probe. -
Administration of Donald J. Trump, 2020 Remarks on Coronavirus
Administration of Donald J. Trump, 2020 Remarks on Coronavirus Vaccine Development November 13, 2020 The President. Thank you very much. Thank you. It's beautiful out here this time of year. In the past 9 months, my administration has initiated the single greatest mobilization in U.S. history, pioneering, developing, and manufacturing therapies and vaccines in record time. Numbers like nobody has seen before. No medical breakthrough of this scope and magnitude has ever been achieved this rapidly, this quickly. And we're very proud of it, and I had tremendous help from the military—generals, admirals—and many of the great people at the White House. Operation Warp Speed is unequaled and unrivaled anywhere in the world, and leaders of other countries have called me to congratulate us on what we've been able to do, and we've helped many countries with their ventilators and all of the problems they were having. And I'd like to congratulate everyone involved in this effort. It's been an incredible effort. As a result of Operation Warp Speed, Pfizer announced on Monday that its "China virus" vaccine is more than 90-percent effective. This far exceeds any and all expectations. Nobody thought they'd get to that level. And we have others coming which we think will be at equal level—maybe more, if that's possible. In July, my administration reached an agreement with Pfizer to provide $1.95 billion to support the mass manufacturing and distribution of 100 million doses, with the option to purchase a total of 600 million doses shortly thereafter. -
Notes from White House Briefing Call 6.10.2020
State, Local, and Tribal Leaders – Thank you to the State, local, and Tribal leaders who joined Vice President Mike Pence and Senior Administration Officials for the White House COVID-19 National Briefing Call on Wednesday, June 10. Attendees heard comprehensive updates and insights on continuing support for State, local, and Tribal response, recovery, and reopening efforts from Vice President Pence, Ambassador Deborah Birx (White House Coronavirus Task Force Coordinator), Secretary Ben Carson (U.S. Department of Housing and Urban Development), Secretary Eugene Scalia (U.S. Department of Labor), and Secretary Betsy DeVos (U.S. Department of Education). The Vice President also expressed his appreciation for the great work and sacrifice from America’s State, local, and Tribal leaders and also asked call attendees to share his, President Trump’s, and the entire Administration’s appreciation for our Nation’s first responders and healthcare workers. Find several examples from State and local leaders here, here, here, here, and here. Below, please find pertinent updates and a recap from the call. Recent Announcements President Trump Hosts Law Enforcement Roundtable: On Monday, President Trump held a roundtable discussion with law enforcement officials at the White House, where officers discussed responsible ideas for reform and ways for police officers to act as better friends for their communities. “There’s a reason for our less crime – it’s because we have great law enforcement. I’m very proud of them. There won’t be defunding, there won’t be dismantling of our police, and there are not going to be any disbanding of our police,” the President stated. -
Vaccines and Related Biological Products Advisory Committee 162Nd Meeting
Food and Drug Administration Center for Biologics Evaluation and Research Vaccines and Related Biological Products Advisory Committee 162nd Meeting December 10, 2020 Web-Conference Silver Spring, Maryland 20993 MEMBERS Chair Acting Chair Hana El Sahly, M.D. + Arnold Monto, M.D. Expertise: Vaccines, Infectious Diseases Thomas Francis Jr. Collegiate Professor Term: 06/21/2019 – 01/31/2022 of Public Health Associate Professor Professor of Epidemiology Department of Molecular Virology and Department of Epidemiology Microbiology University of Michigan Department of Medicine School of Public Health Section of Infectious Diseases Ann Arbor, MI 48109 Baylor College of Medicine Houston, TX 77030 Hayley Gans, M.D. Expertise: Pediatrics, Infectious Diseases Paula Annunziato, M.D. *** Term: 06/21/2019 – 01/31/2023 Expertise: Industry Representative Professor of Pediatrics Term: 2/01/2020 – 01/31/2024 Department of Pediatrics Vice President and Therapeutic Area Head Stanford University Medical Center Vaccines Clinical Research Stanford, CA 94305 Merck North Wales, PA 19454 Holly Janes, Ph.D. + Expertise: Biostatistics Archana Chatterjee, M.D., Ph.D. Term: 02/01/2020 – 01/31/2023 Expertise: Pediatrics, Infectious Diseases Associate Member Term: 06/21/2019 – 01/31/2023 Fred Hutchinson Cancer Research Center Dean Chicago Medical School Vaccine and Infectious Disease Division Vice President for Medical Affairs Division of Public Health Sciences Rosalind Franklin University Seattle, WA 98109 North Chicago, IL 60064 CAPT Amanda Cohn, M.D. Expertise: Pediatrics, -
COVID-19 UPDATE November 23, 2020 Global Total Cases – 59,025,871 Total Deaths – 1,393,889
COVID-19 UPDATE November 23, 2020 Global Total cases – 59,025,871 Total deaths – 1,393,889 United States Total cases – 12,369,978 Total deaths – 257,415 On Wednesday, the United States surpassed 250,000 coronavirus deaths. The total number of patients hospitalized with COVID-19 in the United States has reached new highs every day since November 11, when hospitalizations first surpassed the April peak. One week before the end of the month, the United States has already recorded its highest monthly case total in November, reporting more than 3,075,000 cases. The number of November cases could exceed four million, more than double the total in October. Trump Administration • The Centers for Disease Control and Prevention urged Americans against traveling for Thanksgiving and to limit gatherings to people in the same household as Covid-19 rages in the U.S. o “Celebrating virtually or with the people you live with is the safest choice this Thanksgiving,” the agency said on its website on Thursday. “Travel may increase your chance of getting and spreading COVID-19.” o For people considering traveling for the holiday, the agency offered a checklist of risks and standard advice such as wearing a face covering and staying 6 feet away from people “who don’t live with you.” People hosting Thanksgiving guests at home should observe precautions that could include having an outdoor meal with family and friends, have people bring their own food and drink, and opening windows if the gathering is indoors. • In a call last week, Centers for Disease Control and Prevention Director Robert Redfield and Health and Human Services Secretary Alex Azar encouraged governors to help build confidence in vaccines and stressed the importance of wearing masks. -
COVID-19: a Weekly Health Care Update from Washington April 13-17, 2020
COVID-19: A Weekly Health Care Update from Washington April 13-17, 2020 IN BRIEF What Happened This Week: Negotiators failed to reach consensus on a proposal to provide additional support for small businesses this week (hospital funding was one of the major sticking points, although negotiations are progressing). Meanwhile, at the White House, President Trump and members of the Coronavirus Task Force unveiled the details of a new phased approach to “reopen” the nation’s the economy yesterday and instructed state governors to take the lead. What to Expect in the Weeks and Months Ahead: Expect lawmakers to continue negotiating a path forward for additional small business support; expect lawmakers to continue working remotely on additional measures tied to the pandemic; and expect the Trump Administration to continue providing clarity and guidance on the distribution of funds and implementation of other major provisions in the first three COVID-19 bills. DEEP DIVE President Trump Unveils “Guidelines for Opening Up America Again”; Instructs State Governors to Take the Lead on a Phased Reopening of the Economy President Trump and members of the White House Coronavirus Task Force unveiled the details of a new phased “reopening” of the nation’s economy using a “deliberate, data-driven approach.” The Administration leaves much of the decision-making to the states but instructs them to open up gradually after benchmarks on new cases, testing, and hospital resources are met. As far as timing goes, Coronavirus Task Force Response Coordinator Dr. Deborah Birx said there is no set schedule for any of the guideline’s three phases.